Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENS vs Oxybutynin for Pediatric Overactive Bladder
NCT07892417Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
Randomised, open-label trial in overactive bladder (OAB) and Lower Urinary Tract Dysfunction (LUTD) (2 arms), sponsored by University of Virginia. Primary endpoint: Efficacy of TENS at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
overactive bladder (OAB)Lower Urinary Tract Dysfunction (LUTD)
Beyond the preview
Go deeper on NCT07892417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07892417.